Andrew Bottomley
Brussels, BRU, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 156 publications
Patient-Reported Outcome Instruments in Non-Muscle-Invasive Bladder Cancer (NMIBC): A Systematic Review.
Journal: Oncology and therapy
Published: May 29, 2026
Comparison of the EORTC QLQ-EN24, FACT-En, and FEnSI-23 for assessing quality of life in endometrial cancer: a systematic review.
Journal: Current opinion in supportive and palliative care
Published: May 29, 2026
Comparison of the EORTC QLQ PR25 and the FACT-P for assessing quality of life in patients with prostate cancer - an updated literature review.
Journal: Current opinion in supportive and palliative care
Published: January 29, 2026
Comparing FACIT-fatigue and EORTC QLQ-FA12 for assessing the quality of life in people with cancer-related fatigue.
Journal: Current opinion in supportive and palliative care
Published: December 29, 2025
Use of the EORTC QLQ-BN20 and the FACT-Br for the assessment of quality of life in patients with brain tumors: a systematic review of prospective clinical studies.
Journal: Current opinion in supportive and palliative care
Published: October 14, 2025
Comparing FACT and EORTC QLQ modules for the assessment of quality of life in patients with hepatobiliary cancers.
Journal: Current opinion in supportive and palliative care
Published: July 18, 2025
The Impact of Intravesical Instillations on Quality of Life in Patients with Non-Muscle-Invasive Bladder Cancer: A Systematic Review.
Journal: Oncology and therapy
Published: July 05, 2025
Vorasidenib in IDH1-mutant or IDH2-mutant low-grade glioma (INDIGO): secondary and exploratory endpoints from a randomised, double-blind, placebo-controlled, phase 3 trial.
Journal: The Lancet. Oncology
Published: April 18, 2025
SISAQOL-IMI consensus-based guidelines to design, analyse, interpret, and present patient-reported outcomes in cancer clinical trials.
Journal: The Lancet. Oncology
Published: March 30, 2025
Health-related quality of life in patients with progressive glioblastoma treated with combined bevacizumab and lomustine versus lomustine only: Secondary outcome of the randomized phase III EORTC 26101 study.
Journal: Neuro-oncology practice
Published: March 20, 2025
Evaluation of the EORTC QLQ-C15-PAL and the FACIT-PAL-14 in assessing the quality of life in patients with advanced cancer.
Journal: Current opinion in supportive and palliative care
Published: March 12, 2025
Last Updated: 09/26/2026